Effect of Diclofenac on the Levels of Lipoxin A4 and Resolvin D1 and E1 in the Post-ERCP Pancreatitis

Objectives Acute pancreatitis is one of the most common complications of endoscopic retrograde cholangiopancreatography (ERCP). Numerous studies have shown that administered nonsteroidal anti-inflammatory drugs (NSAIDs) may reduce the incidence of acute pancreatitis after ERCP. Little is known, however, about the mechanism of NSAIDs in preventing pancreatitis (PEP).